178 related articles for article (PubMed ID: 8399083)
1. Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations.
Kotze MJ; De Villiers WJ; Steyn K; Kriek JA; Marais AD; Langenhoven E; Herbert JS; Graadt Van Roggen JF; Van der Westhuyzen DR; Coetzee GA
Arterioscler Thromb; 1993 Oct; 13(10):1460-8. PubMed ID: 8399083
[TBL] [Abstract][Full Text] [Related]
2. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.
Graadt van Roggen JF; van der Westhuyzen DR; Coetzee GA; Marais AD; Steyn K; Langenhoven E; Kotze MJ
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):765-72. PubMed ID: 7773731
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.
Steyn K; Goldberg YP; Kotze MJ; Steyn M; Swanepoel AS; Fourie JM; Coetzee GA; Van der Westhuyzen DR
Hum Genet; 1996 Oct; 98(4):479-84. PubMed ID: 8792826
[TBL] [Abstract][Full Text] [Related]
5. Recurrent LDL-receptor mutation causes familial hypercholesterolaemia in South African coloureds and Afrikaners.
Kotze MJ; Langenhoven E; Theart L; Loubser O; Micklem A; Oosthuizen CJ
S Afr Med J; 1995 May; 85(5):357-61. PubMed ID: 7638684
[TBL] [Abstract][Full Text] [Related]
6. Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia.
Jeenah M; September W; Graadt van Roggen F; de Villiers W; Seftel H; Marais D
Atherosclerosis; 1993 Jan; 98(1):51-8. PubMed ID: 8457250
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas.
Graadt van Roggen F; van der Westhuyzen DR; Marais AD; Gevers W; Coetzee GA
Hum Genet; 1991 Dec; 88(2):204-8. PubMed ID: 1757095
[TBL] [Abstract][Full Text] [Related]
8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
9. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
[TBL] [Abstract][Full Text] [Related]
10. Recurrent and novel LDL receptor gene mutations causing heterozygous familial hypercholesterolemia in La Habana.
Pereira E; Ferreira R; Hermelin B; Thomas G; Bernard C; Bertrand V; Nassiff H; Mendez del Castillo D; Bereziat G; Benlian P
Hum Genet; 1995 Sep; 96(3):319-22. PubMed ID: 7649549
[TBL] [Abstract][Full Text] [Related]
11. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
12. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
Rubinsztein DC; Raal FJ; Seftel HC; Pilcher G; Coetzee GA; van der Westhuyzen DR
Arterioscler Thromb; 1993 Jul; 13(7):1076-81. PubMed ID: 8318509
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
[TBL] [Abstract][Full Text] [Related]
14. Report on a molecular diagnostic service for familial hypercholesterolemia in Afrikaners.
Kotze MJ; Langenhoven E; Theart L; Marx MP; Oosthuizen CJ
Genet Couns; 1994; 5(1):15-21. PubMed ID: 8031531
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia: potential diagnostic value of mutation screening in a pediatric population of South Africa.
Kotze MJ; Peeters AV; Loubser O; Theart L; du Plessis L; Hayes VM; de Jong G; de Villiers JN; Lombard CJ; Hansen PS; Raal FJ
Clin Genet; 1998 Jul; 54(1):74-8. PubMed ID: 9727745
[TBL] [Abstract][Full Text] [Related]
16. South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.
Defesche JC; van Diermen DE; Lansberg PJ; Lamping RJ; Reymer PW; Hayden MR; Kastelein JJ
Hum Genet; 1993 Dec; 92(6):567-70. PubMed ID: 7903269
[TBL] [Abstract][Full Text] [Related]
17. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada.
Pimstone SN; Sun XM; du Souich C; Frohlich JJ; Hayden MR; Soutar AK
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):309-15. PubMed ID: 9484998
[TBL] [Abstract][Full Text] [Related]
19. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
20. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
